About Our Pediatric Hematology/Oncology Program
The Division of Pediatric Hematology/Oncology at UPMC Children’s Hospital of Pittsburgh is the largest, most comprehensive pediatric cancer and blood disease center in western Pennsylvania, eastern Ohio, and northern West Virginia. The Division of Pediatric Hematology/Oncology provides diagnosis, treatment, and complete follow-up for children, adolescents, and young adults with cancer and blood disorders.
Research
The research done in the Division of Pediatric Hematology/Oncology is supported by a number of organizations including the Children's Oncology Group (COG) and the National Institutes of Health (NIH). Researchers have participated in a wide variety of projects, including:
- Immunotherapy for childhood gliomas
- Genetic alterations underlying pediatric melanoma
- Aberrant platelet activation in sickle cell disease
- New tumor suppressor in B-cell Non-Hodgkin Lymphoma
- Tumor Immune response in Ewing Sarcoma
- Optimization of CAR-T cell efficacy through genetic engineering
- Predictors of pediatric pulmonary embolus outcomes
- Patient reported performance status in childhood cancer
- Redox signaling in sickle cell disease
- Risk factors for readmission following febrile neutropenia
- Genetic alterations in pediatric liver tumors
Pediatric Hematology/Oncology Publications from UPMC
